Cite
HARVARD Citation
Bennani, N. et al. (n.d.). Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma. American journal of hematology. 92 (5), pp. 448-453. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bennani, N. et al. (n.d.). Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma. American journal of hematology. 92 (5), pp. 448-453. [Online].